MedPath

Examining the Effectiveness of a Group Cognitive-behavioural Treatment Program for Persistent Genital Arousal Disorder

Not Applicable
Active, not recruiting
Conditions
Persistent Genital Arousal Disorder
Interventions
Behavioral: Cognitive behavioural therapy
Registration Number
NCT05919784
Lead Sponsor
Dr. Caroline Pukall
Brief Summary

This study seeks to provide information regarding the effectiveness of a virtual, synchronous cognitive behavioural therapy (CBT) group program for women with Persistent Genital Arousal Disorder/Genitopelvic Dysesthesia (PGAD/GPD). The program consists of 8 weekly sessions of two hours each, which focus on education and understanding, and learning skills and strategies to manage PGAD/GPD symptoms, and related mental health and lifestyle impacts, as well as structured opportunities for discussion and shared reflection. The group therapy program involves elements based in Cognitive Behavioural Therapy (CBT), Acceptance and Commitment Therapy (ACT), and Dialectical Behaviour Therapy (DBT). Participants in the present study will provide responses to online surveys (before, during, and immediately after treatment, also 3 and 6 months after treatment) regarding their PGAD/GPD symptoms, mental health symptoms, and sexual wellness (sexual pleasure and distress).

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
25
Inclusion Criteria
  • at least 18 years of age
  • fluent in English
  • have a physician-based diagnosis of PGAD/GPD
  • reside in Ontario, Canada
  • be comfortable answering questions about their health (mental and physical) and sexuality in online surveys
  • be comfortable discussing their mental and physical health and PGAD/GPD symptoms in group online therapy sessions with video on
Exclusion Criteria
  • under the age of 18 years
  • nonfluent in English
  • lack of physician based diagnosis of PGAD/GPD
  • not comfortable with answering questions about mental, physical, sexual health
  • not comfortable with discussing mental and physical health and PGAD/GPD symptoms in group online therapy sessions with video on
  • mental or physical health conditions that preclude involvement in group therapy

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Cognitive behavioural therapyCognitive behavioural therapyThe group therapy program (virtual, synchronous) involves elements based in Cognitive Behavioural Therapy (CBT), Acceptance and Commitment Therapy (ACT), and Dialectical Behaviour Therapy (DBT).
Primary Outcome Measures
NameTimeMethod
Symptom distress6 months after the end of the program

Symptom distress on a scale of 0 (no distress) to 10 (extreme distress). Range is 0-10. Higher scores are worse.

Symptom intensity6 months after the end of the program

Symptom intensity on a scale of 0 (no symptoms) to 10 (extremely intense symptoms). Range is 0-10. Higher scores are worse.

Secondary Outcome Measures
NameTimeMethod
Symptom catastrophizing6 months after the end of the program

Pain Catastrophizing Scale, adapted to symptoms. Range is 0-52. Higher scores are worse.

Symptom self-efficacy6 months after the end of the program

Pain Self-Efficacy Scale, adapted to symptoms. Range is 0-60. Higher scores are better.

Resilience6 months after the end of the program

Brief Resilience Scale. Range is 6-30. Higher scores are better.

Trial Locations

Locations (1)

Sexual Health Research Laboratory, Department of Psychology, Queen's University

🇨🇦

Kingston, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath